Jennifer Cunliffe

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Chiesi (United States)

Sanofi (United States)

Health Canada

Pfizer (United States)

Jennifer Cunliffe is an author at Ionis Pharmaceuticals (United States) specializing in clinical biochemistry, biomedical sciences, and bioanalytical methodology.

Publications per year

2023–2024

Publications

2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( Part 1A – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)

Matt Szapacs, Wenying Jian, Daniel S. Spellman et al. · Bioanalysis · 2023 · 17 citations

Pharmacy, Biomedical Sciences, Analytical Toxicology +13

2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody (PART 1A – Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis PART 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)

Mike Baratta, Wenying Jian, Shawna Hengel et al. · Bioanalysis · 2024 · 11 citations · Full text

Medicine, Biomedical Sciences, Pharmacology +15

1–2 of 2